http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2672555-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f172a29a65f5edfabb7daa1a58d9a57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1192c9b9c89209f519b3d8d1b8a215b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047b05618f81d54c1ef54702f99a2e29 |
| publicationDate | 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2672555-C2 |
| titleOfInvention | Combination of pi3 kinase inhibitor with paclitaxel for use in treatment or prevention of head and neck cancer |
| abstract | FIELD: medicine; pharmaceuticals. n SUBSTANCE: invention relates to a pharmaceutical combination comprising phosphatidylinositol-3-kinase (PI3K) inhibitor compound of formula (I) as defined herein or a pharmaceutically acceptable salt thereof and paclitaxel or a pharmaceutically acceptable salt thereof, for simultaneous, separate or sequential use in the treatment of head and neck cancer; pharmaceutical composition comprising said combination; use of said combination for the preparation of a medicament for the treatment of head and neck cancer; method for treating or preventing head and neck cancer comprising administering together a therapeutically effective amount of a combination to a subject in need thereof. n EFFECT: combination of a PI3 kinase inhibitor with paclitaxel has been proposed for use in the treatment or prevention of head and neck cancer. n 15 cl, 2 ex, 1 tbl, 2 dwg |
| priorityDate | 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 188.